NASDAQ:IMNM News 15 December 2025

Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

Immunome shares rose 7.4% to $21.97 Friday after recent Phase 3 data showed its lead drug varegacestat cut disease progression or death by 84% in desmoid tumor patients. The company plans to file for FDA approval in Q2 2026. Immunome also granted stock options to three new hires and will present at the J.P. Morgan Healthcare Conference on Jan. 14.

9 January 2026

NASDAQ:IMNM·NASDAQ:SWTX·Stock Market·XETRA:MRK

Immunome (IMNM) stock drops 5% as biotech slips; investors look to Jan. 14 update

Immunome shares fell 5.3% to $19.72 in late trading Monday, underperforming biotech indexes and dropping below December’s $21.50 offering price. About 1.6 million shares changed hands by 3:54 p.m. EST. The company’s next update is expected at the J.P. Morgan Healthcare Conference on Jan. 14. No new company news has been released since December 16.

5 January 2026

NASDAQ:IMNM·Stock Market

Immunome (IMNM) Stock Surges After Positive Phase 3 Varegacestat Data: Latest News, Analyst Forecasts, and What Comes Next (Dec. 15, 2025)

December 15, 2025 — Immunome, Inc. (NASDAQ: IMNM) is having the kind of biotech day that traders circle in red ink: a major clinical trial win, a sharp move in the share price, and a fast-rising debate over what “best-in-class” might be worth if regulators agree. The catalyst is Immunome’s positive topline Phase 3 RINGSIDE results for varegacestat (formerly AL102) in progressing desmoid tumors—a rare, non-metastatic but often aggressive disease that can cause severe pain and disability. Reuters reported the news pushed the stock up 34.3% in premarket trading Monday. Reuters By mid-session, IMNM remained strongly higher. As of 14:46

15 December 2025

NASDAQ:IMNM

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

7 February 2026

New York, Feb 7, 2026, 10:23 EST — Market closed. Walmart Inc (WMT) shares rose 3.34% on Friday to close at $131.18, lifting the retailer’s market value to about $1.05 trillion. The stock traded between $126.03 and $131.69 and saw about 26.6 million shares change hands. (TradingView) The move came as a broad rally pushed the Dow Jones Industrial Average above 50,000 for the first time, with investors widening their focus beyond technology. “What’s driven it recently has been the broadening … other than just the tech, AI trade,” said Chuck Carlson, chief executive at Horizon Investment Services. (reuters.com) Markets

Visa stock price closes higher as $100 million small-business push hits tape — what to watch next week

7 February 2026

Visa shares closed up 0.74% at $331.58 Friday, trading between $327.10 and $335.13. The company launched “Visa & Main,” a small-business platform with a $100 million working-capital facility through Lendistry. Mastercard fell 0.6%, while American Express and PayPal each rose about 1.3%. Investors await next week’s U.S. jobs and inflation data.

Samsung Electronics stock price slips to 158,600 won as tech selloff bites; Monday in focus

7 February 2026

Samsung Electronics shares closed down 0.44% at 158,600 won Friday, with 36 million shares traded as the Kospi fell 1.4%. Investors are watching chip demand and AI-related trades after Samsung gained 32% year-to-date. Samsung secured partial occupancy for its Taylor, Texas chip plant. Next trading is Monday, ahead of a Feb. 10 investor event.

Berkshire Hathaway stock price: BRK.B ends at $508 as Dow tops 50,000 — what to watch next week

7 February 2026

Berkshire Hathaway’s Class B shares rose 0.83% to $508.09 Friday, trading between $502.89 and $509.66. The Dow closed above 50,000 for the first time, while the S&P 500 and Nasdaq jumped as chipmakers led a rebound. Investors are watching if Berkshire holds above $500 when markets reopen Monday.

NASDAQ:IMNM News 15 December 2025 - 9 January 2026

Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

Immunome (IMNM) stock drops 5% as biotech slips; investors look to Jan. 14 update

Immunome (IMNM) Stock Surges After Positive Phase 3 Varegacestat Data: Latest News, Analyst Forecasts, and What Comes Next (Dec. 15, 2025)

Stock Market Today

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

Visa stock price closes higher as $100 million small-business push hits tape — what to watch next week

Samsung Electronics stock price slips to 158,600 won as tech selloff bites; Monday in focus

Berkshire Hathaway stock price: BRK.B ends at $508 as Dow tops 50,000 — what to watch next week